1. Home
  2. ASND vs COO Comparison

ASND vs COO Comparison

Compare ASND & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$259.21

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Logo The Cooper Companies Inc.

COO

The Cooper Companies Inc.

HOLD

Current Price

$70.69

Market Cap

12.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASND
COO
Founded
2006
1980
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
12.9B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
ASND
COO
Price
$259.21
$70.69
Analyst Decision
Strong Buy
Buy
Analyst Count
16
11
Target Price
$281.50
$90.18
AVG Volume (30 Days)
671.6K
3.6M
Earning Date
05-12-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.27
Revenue
N/A
$2,532,800,000.00
Revenue This Year
$96.35
$6.66
Revenue Next Year
$44.91
$5.18
P/E Ratio
N/A
$261.30
Revenue Growth
N/A
18.41
52 Week Low
$161.09
$58.89
52 Week High
$271.89
$89.83

Technical Indicators

Market Signals
Indicator
ASND
COO
Relative Strength Index (RSI) 68.16 67.72
Support Level $213.28 $67.91
Resistance Level N/A $72.07
Average True Range (ATR) 11.32 1.84
MACD 4.80 0.48
Stochastic Oscillator 79.96 80.31

Price Performance

Historical Comparison
ASND
COO

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

About COO The Cooper Companies Inc.

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Share on Social Networks: